1. Repligen Appoints Rohin Mhatre, Ph.D. to Board of Directors

    Repligen Appoints Rohin Mhatre, Ph.D. to Board of Directors

    WALTHAM, Mass., Feb. 27, 2020 (GLOBE NEWSWIRE) --Repligen Corporation (NASDAQ:RGEN) today announced the appointment of life sciences industry executive Rohin Mhatre, Ph.D., to its Board of Directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned